Press Releases
Search
-
27 Jul 2011
New Study Reports: CancerTYPE ID Expands Tumor Type Coverage and Demonstrates Clinical Utility - CancerTYPE ID is Now a Covered Benefit for Medicare Part B Patients
SAN DIEGO, Calif., - July 27, 2011. bioTheranostics, a bioMérieux company that develops innovative oncology diagnostic tests to support targeted disease management, announced today study results publi...
-
22 Jul 2011
Completion of the AES Chemunex group acquisition and filing of a tender offer for the AES Chemunex shares
Marcy-l’Etoile, France - July 22, 2011. bioMérieux has today acquired the entire capital and voting rights of Skiva (441 886 728 R.C.S. Paris), the parent company of the AES Chemunex group. Through th...
-
19 Jul 2011
bioMérieux Expands its Infectious Disease Offering with Acquisition of ARGENE, Specialized in Molecular Diagnostics for Immunocompromised Patients
Marcy l'Etoile, France - July 19, 2011 . bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has acquired ARGENE, a French company specialized in molecular diagnostics. ...
-
30 Jun 2011
World HAI Forum: Global Call to Action to Fight Antibiotic Resistance
Annecy (France) - June 30, 2011 . Over 70 international experts in medicine, infectious diseases, microbiology and epidemiology, from every continent, gathered at the Fondation Mérieux’s Conference Ce...
-
22 Jun 2011
bioMérieux Launches Groundbreaking Salmonella Detection Technology to Improve Food Safety
Marcy l’Etoile - June 22, 2011. bioMérieux, a world leader in the field of in vitro diagnostics, today announced the launch of a new, innovative food safety testing method, VIDAS® UP Salmonella (SPT).
-
24 May 2011
bioMérieux Receives FDA Clearance for NucliSENS EasyQ® MRSA, Automated, Rapid Molecular Screening Test
Marcy l’Etoile, France - May 24, 2011 . bioMérieux, a world leader in the field of in vitro diagnostics, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA...